Sweet urine, bitter outcome: Empagliflozin and balanoposthitis

+Summer Hiatus
In print
Practice + Sexual health

Sweet urine, bitter outcome: Empagliflozin and balanoposthitis

By Massimo Giola
Sugar
Urine loaded with sugar offers an excellent growth medium for fungi and bacteria [Image: Mikhail Nilov on Pexels]

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!

This article was first published online on 14 February.

Sexual health specialist Massimo Giola continues his series of short, mostly clinical case-based sexual health articles. This year, he has in mind a mix of transgender medicine and sexology topics, but he starts with a genital dermatology issue he has seen a few times recently

Key points, Sodium-glucose cotransporter-2 inhibitors (dapagliflozin and empagliflozin) work by causing glycosuria. Urinary tract infections and genital fungal , Pract Green w Pale Yellow
References

1. Johnsson KM, Ptaszynska A, Schmitz B, et al. Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin. J Diabetes Complications 2013;27(5):479–84.

2. Nyirjesy P, Sobel JD, Fung A, et al. Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies. Curr Med Res Opin 2014;30(6):1109–19.